Review highlights persistent therapeutic challenges in treatment-resistant depression, emphasizing the need for novel drug development to improve quality of life.
Treatment-resistant depression continues to challenge mental health care providers, and further relevant research involving newer drugs is warranted to improve the quality of life of patients with the disorder.
No takes yet. Share an insight, caveat, or question.
Alharbi Alharbi (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: